{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:29:50Z","timestamp":1770492590970,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00330-020-07496-z","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T20:02:50Z","timestamp":1609704170000},"page":"5370-5378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Percutaneous thermoablation of small renal masses (T1a) in surgical candidate patients: oncologic outcomes"],"prefix":"10.1007","volume":"31","author":[{"given":"Renato N.","family":"Zangiacomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme L. P.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00fablio C. C.","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natally","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Arap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Nahas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Srougi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni G.","family":"Cerri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7548-8774","authenticated-orcid":false,"given":"Marcos R.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"7496_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296\u20131305","journal-title":"N Engl J Med"},{"key":"7496_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","volume":"62","author":"J Himmelfarb","year":"2002","unstructured":"Himmelfarb J, Stenvinkel P, Ikizler T, Hakim R (2002) Perspectives in renal medicine: the elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524\u20131538","journal-title":"Kidney Int"},{"key":"7496_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.juro.2009.07.004","volume":"182","author":"SC Campbell","year":"2009","unstructured":"Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271\u20131279","journal-title":"J Urol"},{"key":"7496_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0022-5347(05)67896-2","volume":"163","author":"AF Fergany","year":"2000","unstructured":"Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163:442\u2013445","journal-title":"J Urol"},{"key":"7496_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.eururo.2005.12.049","volume":"49","author":"G Pasticier","year":"2006","unstructured":"Pasticier G, Timsit MO, Badet L et al (2006) Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol 49:485\u2013490","journal-title":"Eur Urol"},{"key":"7496_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.eururo.2015.01.025","volume":"68","author":"A Volpe","year":"2015","unstructured":"Volpe A, Blute ML, Ficarra V et al (2015) Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 68:61\u201374","journal-title":"Eur Urol"},{"key":"7496_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/bju.12366","volume":"113","author":"Y Ma","year":"2014","unstructured":"Ma Y, Bedir S, Cadeddu JA, Gahan JC (2014) Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int 113:51\u201355","journal-title":"BJU Int"},{"key":"7496_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.eururo.2010.06.032","volume":"58","author":"B Ljungberg","year":"2010","unstructured":"Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398\u2013406","journal-title":"Eur Urol"},{"key":"7496_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2015","unstructured":"Ljungberg B, Bensalah K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913\u2013924","journal-title":"Eur Urol"},{"key":"7496_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2017.04.100","volume":"198","author":"S Campbell","year":"2017","unstructured":"Campbell S, Uzzo RG, Allaf ME et al (2017) Renal mass and localized renal cancer: AUA guideline. J Urol 198:520\u2013529","journal-title":"J Urol"},{"key":"7496_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1200\/JCO.2016.69.9645","volume":"35","author":"A Finelli","year":"2017","unstructured":"Finelli A, Ismaila N, Bro B et al (2017) Management of small renal masses: American society of clinical oncology clinical practice guideline. J Clin Oncol 35:668\u2013680","journal-title":"J Clin Oncol"},{"key":"7496_CR12","doi-asserted-by":"crossref","unstructured":"Escudier B, Porta C, Schmidinger M et al (2019) Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30:706\u2013720","DOI":"10.1093\/annonc\/mdz056"},{"key":"7496_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.eururo.2012.08.062","volume":"63","author":"S Psutka","year":"2012","unstructured":"Psutka S, Feldman AS, McDougal WS, McGovern F, Mueller P, Gervais D (2012) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63:486\u2013492","journal-title":"Eur Urol"},{"key":"7496_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.eururo.2014.07.021","volume":"67","author":"RH Thompson","year":"2015","unstructured":"Thompson RH, Atwell T, Schmit G et al (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67:252\u2013259","journal-title":"Eur Urol"},{"key":"7496_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/bju.12349","volume":"113","author":"TM Wah","year":"2014","unstructured":"Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ (2014) Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int 113:416\u2013428","journal-title":"BJU Int"},{"key":"7496_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.ju.0000162046.45024.2b","volume":"174","author":"WS McDougal","year":"2005","unstructured":"McDougal WS, Gervais DA, McGovern FJ, Mueller PR (2005) Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 174:61\u201363","journal-title":"J Urol"},{"key":"7496_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1464-410X.2009.08443.x","volume":"104","author":"JM Stern","year":"2009","unstructured":"Stern JM, Gupta A, Raman JD et al (2009) Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome. BJU Int 104:786\u2013789","journal-title":"BJU Int"},{"key":"7496_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.eururo.2010.08.007","volume":"58","author":"S Eggener","year":"2010","unstructured":"Eggener S (2010) TNM staging for renal cell carcinoma: time for a new method. Eur Urol 58:517\u2013521","journal-title":"Eur Urol"},{"key":"7496_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-0033-1363842","volume":"31","author":"AN Kurup","year":"2014","unstructured":"Kurup AN (2014) Percutaneous ablation for small renal masses-complications. Semin Intervent Radiol 31:42\u201349","journal-title":"Semin Intervent Radiol"},{"key":"7496_CR20","unstructured":"European Association Urology (2014) Guidelines on reporting and grading of complications after urologic surgical procedures. European Association Urology. Available via https:\/\/uroweb.org\/wp-content\/uploads\/30-Reporting-complications_LR.pdf. Accessed 13 Oct 2016"},{"key":"7496_CR21","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.jvir.2014.09.005","volume":"25","author":"M Ahmed","year":"2014","unstructured":"Ahmed M (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update: supplement to the consensus document. J Vasc Interv Radiol 25:1706\u20131708","journal-title":"J Vasc Interv Radiol"},{"key":"7496_CR22","doi-asserted-by":"publisher","first-page":"S377","DOI":"10.1016\/j.jvir.2009.04.011","volume":"20","author":"SN Goldberg","year":"2009","unstructured":"Goldberg SN, Grassi CJ, Cardella JF et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377\u2013S390","journal-title":"J Vasc Interv Radiol"},{"key":"7496_CR23","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.juro.2008.07.047","volume":"180","author":"PL Crispen","year":"2008","unstructured":"Crispen PL, Boorjian SA, Lohse CM et al (2008) Outcomes following partial nephrectomy by tumor size. J Urol 180:1912\u20131917","journal-title":"J Urol"},{"key":"7496_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.7326\/M17-0585","volume":"169","author":"AD Talenfeld","year":"2018","unstructured":"Talenfeld AD, Gennarelli RL, Elkin EB et al (2018) Percutaneous ablation versus partial and radical nephrectomy for T1a renal cancer: a population-based analysis. Ann Intern Med 169:69\u201377","journal-title":"Ann Intern Med"},{"key":"7496_CR25","doi-asserted-by":"publisher","first-page":"e13102","DOI":"10.1097\/MD.0000000000013102","volume":"97","author":"YE Yoon","year":"2018","unstructured":"Yoon YE, Lee HH, Kim KH et al (2018) Focal therapy versus robot-assisted partial nephrectomy in the management of clinical T1 renal masses: a systematic review and meta-analysis. Medicine (Baltimore) 97:e13102","journal-title":"Medicine (Baltimore)"},{"key":"7496_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.eururo.2014.12.028","volume":"67","author":"JE Choi","year":"2015","unstructured":"Choi JE, You JH, Kim DK, Rha KH, Lee SH (2015) Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol 67:891\u2013901","journal-title":"Eur Urol"},{"key":"7496_CR27","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1089\/end.2013.0192","volume":"27","author":"YS Tanagho","year":"2013","unstructured":"Tanagho YS, Bhayani SB, Kim EH, Figenshau RS (2013) Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience. J Endourol 27:1477\u20131486","journal-title":"J Endourol"},{"key":"7496_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.asjsur.2014.09.005","volume":"38","author":"SH Kim","year":"2015","unstructured":"Kim SH, Lee ES, Kim HH et al (2015) A propensity-matched comparison of perioperative complications and of chronic kidney disease between robot-assisted laparoscopic partial nephrectomy and radiofrequency ablative therapy. Asian J Surg 38:126\u2013133","journal-title":"Asian J Surg"},{"key":"7496_CR29","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s00330-018-5305-6","volume":"28","author":"BK Park","year":"2018","unstructured":"Park BK, Gong IH, Kang MY et al (2018) RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome. Eur Radiol 28:2979\u20132985","journal-title":"Eur Radiol"},{"key":"7496_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","volume":"59","author":"H Van Poppel","year":"2011","unstructured":"Van Poppel H, Da Pozzo L, Albrecht W et al (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59:543\u2013552","journal-title":"Eur Urol"},{"key":"7496_CR31","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.ejso.2019.05.010","volume":"45","author":"X Hu","year":"2019","unstructured":"Hu X, Shao YX, Wang Y, Yang ZQ, Yang WX, Li X (2019) Partial nephrectomy versus ablative therapies for cT1a renal masses: a systematic review and meta-analysis. Eur J Surg Oncol 45:1527\u20131535","journal-title":"Eur J Surg Oncol"},{"key":"7496_CR32","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.eururo.2012.01.001","volume":"61","author":"EO Olweny","year":"2012","unstructured":"Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA (2012) Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 61:1156\u20131161","journal-title":"Eur Urol"},{"key":"7496_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.eururo.2019.04.026","volume":"76","author":"JR Andrews","year":"2019","unstructured":"Andrews JR, Atwell T, Schmit G et al (2019) Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 76:244\u2013251","journal-title":"Eur Urol"},{"key":"7496_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.juro.2016.04.081","volume":"196","author":"PM Pierorazio","year":"2016","unstructured":"Pierorazio PM, Johnson MH, Patel HD et al (2016) Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol 196:989\u2013999","journal-title":"J Urol"},{"key":"7496_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.urology.2016.10.047","volume":"100","author":"JY An","year":"2017","unstructured":"An JY, Ball MW, Gorin MA et al (2017) Partial vs radical nephrectomy for T1-T2 renal masses in the elderly: comparison of complications, renal function, and oncologic outcomes. Urology 100:151\u2013157","journal-title":"Urology"},{"key":"7496_CR36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ijsu.2016.05.070","volume":"36","author":"N Raison","year":"2016","unstructured":"Raison N, Doeuk N, Malthouse T, Kasivisvanathan V, Lam W, Challacombe B (2016) Challenging situations in partial nephrectomy. Int J Surg 36:568\u2013573","journal-title":"Int J Surg"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-020-07496-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:05:35Z","timestamp":1624010735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-020-07496-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["7496"],"URL":"https:\/\/doi.org\/10.1007\/s00330-020-07496-z","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Prof. Marcos Roberto de Menezes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Gabriel Liguori and Rog\u00e9rio Ruscitto do Prado kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 Retrospective;\u2022 Case-control study;\u2022 Bi-institutional study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}